Effect of oral Eicosapentaenoic acid on weight loss in patients with pancreatic cancer

Nutrition and Cancer

Volumn 36, Issue 2, 2000, Pages 177-184

  Wigmore, Stephen J ^a   Barber, Matthew D ^a   Ross, James A ^a   Tisdale, Michael J ^b   Fearon, Kenneth C H ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; FISH OIL; ICOSAPENTAENOIC ACID;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BODY COMPOSITION; CACHEXIA; CLINICAL ARTICLE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG CAPSULE; FEMALE; HUMAN; MALE; PANCREAS CANCER; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0033918233     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC3602_6     Document Type: Article

References (31)

1. Wigmore, SJ, Plester, CE, Richardson, RA, Ross, JA, and Fearon, KCH: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75, 106-109, 1997.
2. DeWys, WD, Begg, C, Lavin, PT, Band, PR, Bennett, JM, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69, 491-497, 1980.
3. Oveson, L, Hannibal, J, and Mortensen, EL: The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer 19, 159-167, 1993.
4. Ng, E-H, and Lowry, SF: Nutritional support and cancer cachexia. Evolving concepts of mechanisms and adjunctive therapies. Hematol Oncol Clin North Am 5, 161-184, 1991.
5. Moldawer, LL, and Copeland, EM: Proinflammatory cytokines, nutritional support, and the cachexia syndrome. Interactions and therapeutic options. Cancer 79, 1828-1839, 1997.
6. McNamara, MJ, Alexander, HR, and Norton, JA: Cytokines and their role in the pathophysiology of cancer cachexia. J Parent Enteral Nutr 16 Suppl, 50S-55S, 1992.
7. Falconer, JS, Fearon, KCH, Plester, CE, Ross, JA, and Carter, DC: Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219, 325-331, 1994.
8. Wigmore, SJ, Plester, CE, Ross, JA, and Fearon, KCH: Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84, 196-197, 1997.
9. Falconer, JS, Fearon, KCH, Ross, JA, Elton, RE, Wigmore, SJ, et al.: The acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75, 2077-2082, 1995.
10. Heinrich, PC, Castell, JV, and Andus, T: Interleukin-6 and the acute phase response. Biochem J 265, 621-636, 1990.
11. Endres, S, Ghorbani, R, Kelley, VE, Georgilis, K, Lonnemann, G, et al.: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320, 265-271, 1989.
12. Wigmore, SJ, Fearon, KCH, Maingay, JP, and Ross, JA: Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci 92, 215-221, 1997.
13. Falconer, JS, Ross, JA, Fearon, KCH, Tisdale, MJ, Hawkins, AH, et al.: Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer 69, 826-832, 1994.
14. Beck, SA, Smith, KL, and Tisdale, MJ: Anticachectic and antitumour effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res 51, 6089-6093, 1991.
15. Tisdale, MJ: Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition 12 Suppl, S31-S33, 1996.
16. Wigmore, SJ, Ross, JA, Falconer, JS, Plester, CE, Tisdale, MJ, et al.: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12 Suppl, S27-S30, 1996.
17. Jelliffe, DB: The Assessment of the Nutritional Status of the Community. Geneva, Switzerland: World Health Organization, 1966. (WHO Monogr 53)
18. Hannan, WJ, Cowen, SJ, Plester, CE, Fearon, KCH, and de Beaux, AC: Comparison of bioimpedance spectroscopy and multi-frequency bioimpedance analysis for the assessment of extracellular and total body water in surgical patients. Clin Sci 89, 651-658, 1995.
19. Cohn, SH, Vartsky, D, Vaswani, AN, Sawitsky, A, Rai, K, et al.: Changes in body composition of cancer patients following combined nutritional support. Nutr Cancer 4, 107-119, 1982.
20. Lai, PBS, Ross, JA, Fearon, KCH, Anderson, JD, and Carter, DC: Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 74, 1375-1383, 1996.
21. Todorov, P, Cariuk, P, McDevitt, T, Coles, B, Fearon, KCH, et al.: Characterization of a cancer cachectic factor. Nature 379, 739-742, 1996.
22. Mor, V: Cancer patients, quality of life over the disease course: lessons from the real world. J Chron Dis 40, 535-544, 1987.
23. Ahlgren, JD: Epidemiology and risk factors in pancreatic cancer. Semin Oncol 23, 241-250, 1996.
24. Fearon, KCH, Falconer, JS, Ross, JA, Carter, DC, Hunter, JO, et al.: An open-label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gamma-linolenate. Anticancer Res 16, 867-874, 1996.
25. Leaf, A, and Weber, PC: Cardiovascular effects of n-3 fatty acids. N Engl J Med 318, 549-554, 1998.
26. Cersosimo, E, Pisters, PWT, Pesola, G, McDermott, K, Bajournas, D, et al: Insulin secretion and actions in patients with pancreatic cancer. Cancer 67, 486-493, 1991.
27. Glauber, H, Wallace, P, Griver, K, and Brechtel, G: Adverse effect of ω-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108, 663-068, 1988.
28. Borkman M, Chisholm, DJ, Furler, SM, Storlien, LH, Kraegen, EW, et al.: Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38, 1314-1319, 1989.
29. van Houwelingen, R, Nordøy, A, van der Beek, E, Houtsmuller, U, de Metz, M, et al.: Effect of a moderate fish intake on blood pressure, bleeding time, hematology and clinical chemistry in healthy males. Am J Clin Nutr 46, 424-436, 1987.
30. Clarke, JTR, Cullen-Dean, G, Regelink, E, Chan, L, and Rose, V: Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil. J Pediatr 116, 139-141, 1990.
31. Calder, PC: Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Proc Nutr Soc 55, 737-774, 1996.